Novartis AG - Goodwill and Other Intagible Assets
Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Goodwill-and-Other-Intagible-Assets" stands at 69.03 Billion United States Dollars as of 06/30/2026, the highest value since 03/31/2019.
As of the end of Novartis AG's second quarter, the item "Goodwill and Other Intagible Assets" stands at 69.03 Billion USD. This represents an increase of 2.67 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.98 percent compared to the value the year prior.
The 1 year change in percent is 25.98.
The 3 year change in percent is 19.99.
The 5 year change in percent is 6.88.
The 10 year change in percent is 6.62.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 06/30/2026, is +39.91%.
The Serie's change in percent from it's maximum value, on 06/30/2018, to it's latest available value, on 06/30/2026, is -7.48%.
Goodwill and Other Intagible Assets for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Goodwill and Other Intagible Assets | 905,699,262,464.00 |
 | Johnson & Johnson - Goodwill and Other Intagible Assets | 486,508,953,600.00 |
 | AbbVie Inc - Goodwill and Other Intagible Assets | 399,570,305,024.00 |
 | Roche Holding AG - Goodwill and Other Intagible Assets | 317,433,206,677.55 |
 | AstraZeneca PLC - Goodwill and Other Intagible Assets | 280,205,508,085.11 |